926P Real-world data in the era of immune checkpoint inhibitors (ICIs): Cetuximab-containing first-line therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 31; p. S667
Main Authors Fu-Ming, C., Hsieh, C-Y., Wang, T-H., Tsai, M-H., Hua, C-H., Tang, C-H., Hsieh, C-H., Lien, M-Y.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2020
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2020.08.1041